As of Dec 09
| -0.03 / -0.53%|
The 2 analysts offering 12-month price forecasts for Cascadian Therapeutics Inc have a median target of 18.00, with a high estimate of 18.00 and a low estimate of 18.00. The median estimate represents a +218.58% increase from the last price of 5.65.
The current consensus among 2 polled investment analysts is to Buy stock in Cascadian Therapeutics Inc. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.